Cargando…
Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats
Abelmoschus esculentus (AE) has been used in traditional medicine to ameliorate hyperglycemia, but its mucilage increased bioassay difficulties. We have obtained a series of AE subfractions. Among them F1 and F2 regulated dipeptidyl peptidase-4 (DPP-4) and type 1 glucagon-like peptide receptor (GLP-...
Autores principales: | Peng, Chiung-Huei, Lin, Hsing-Chun, Lin, Chih-Li, Wang, Chau-Jong, Huang, Chien-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298636/ https://www.ncbi.nlm.nih.gov/pubmed/30648566 http://dx.doi.org/10.1016/j.jfda.2018.07.004 |
Ejemplares similares
-
The nutraceutical benefits of subfractions of Abelmoschus esculentus in treating type 2 diabetes mellitus
por: Huang, Chien-Ning, et al.
Publicado: (2017) -
Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4—With improving insulin resistance
por: Peng, Chiung-Huei, et al.
Publicado: (2022) -
Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced β cell apoptosis via inhibiting dipeptidyl peptidase-4
por: Huang, Chien-Ning, et al.
Publicado: (2017) -
Abelmoschus esculentus subfractions attenuate Aβ and tau by regulating DPP-4 and insulin resistance signals
por: Huang, Chien-Ning, et al.
Publicado: (2020) -
Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals
por: Huang, Chien-Ning, et al.
Publicado: (2019)